What We're Reading: Page 214
Industry reads hand-picked by our editors
Dec 05, 2019
Dec 04, 2019
Dec 03, 2019
Dec 02, 2019
-
The New York Times
New Strawberry-Flavored H.I.V. Drugs for Babies Are Offered at $1 a Day
-
POLITICO
Senate quicksand engulfs a bipartisan plan that Trump backs
-
The Wall Street Journal
GE Pitches Investors on Its Health-Care Unit, a Steady Source of Cash
Nov 27, 2019
-
Fortune
How Sanofi's Breakthrough Dengue Fever Vaccine Caused an Epidemic of Fear
-
POLITICO
Clashes among top HHS officials undermine Trump agenda
-
Reuters
Pfizer, Novartis lead pharma spending spree on gene therapy production
-
OneZero
There Still Aren’t Any Rules Preventing Rogue Scientists From Making Gene-Edited Babies
Nov 26, 2019
-
Bloomberg
HLB's Cancer Drug Won Plaudits But There Was No Award
-
Reuters
Blackstone to invest $400 million in gene therapy venture with Ferring
-
Financial Times
South Korea’s SK Biopharmaceuticals plans to raise $850m in IPO
-
Endpoints News
Ex-Purdue CEO stands to earn a huge windfall in Novartis' buyout of the Medicines Co
Previous
